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showed that MMP-2, -7, -9, -12, -14, -15, and -25 are expressionally
correlated with the tumor grade. The data for MMP-1, -11, -19 and
-24 are contradictory, since some studies, including our own, sug-
gest involvement during brain tumor development, whereas the
results of other groups deny such connection. The remaining
MMPs do not seem to play a major role during glioblastoma devel-
opment, because they are either constitutively expressed or not
expressed at all.
Conclusion: This is the first complete compilation of expression
of all 23 human MMPs by astrocytic tumors. Specific MMP expres-
sion patterns may mark tumor aggressiveness. Expression stud-
ies will extend our understanding of tumor invasiveness and
help us to find more effective therapeutic means for treatment
of glioblastomas.
doi:10.1016/j.ejcsup.2006.04.067
P8. THE SERINE PROTEASE Bssp REGULATES
KERATINOCYTE PROLIFERATION AND MIGRATION BY
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Background: Carcinogenesis is a multistage process driven by
genetic and epigenetic alterations that are associated with
changes in the expression or function of oncogenes and tumor-
suppressor genes.
Methods: In order to identify novel tumor-associated genes, we
performed global gene expression profiling with specimens of a
well-established multistage tumor model of mouse skin resulting
in a comprehensive list of differentially expressed genes.
Results: One of these genes encodes for the secreted serine pro-
tease Bssp and is characterized by elevated expression in
advanced stages of mouse skin tumors. Moreover, we found
enhanced levels of kallikrein 6, the human homolog, in malignant
squamous skin tumors of human patients as well as in tumors of
other epithelial tissues suggesting a common role in carcinogen-
esis. To unravel the consequence of elevated Bssp expression in
epithelial cells, we established stable transfected keratinocytes
expressing exogenous Bssp. These cells displayed increased pro-
liferation and advanced migration accompanied by impaired
E-cadherin-mediated cell–cell adhesion and increased nuclear b-
catenin localization. Enhanced proliferation of keratinocytes
was confirmed in a wound healing experiment using a transgenic
mouse model with exogenous Bssp expression in skin.
Conclusion: In summary our data imply that elevated Bssp/Klk6
levels support epithelial neoplasia due to modulation of E-cad-
herin/b-catenin signalling and thereby facilitate proliferation
and migration of tumor cells.
doi:10.1016/j.ejcsup.2006.04.068P9. Eps8 ASSOCIATES WITH ACTIN AT THE LEADING EDGE
AND INDICATES MIGRATORY POTENTIAL IN PANCREATIC
CANCER CELL LINES
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Background: Pancreatic carcinoma is characterized by early
metastasis. Increased cell motility is critical for metastasis of
tumor cells. Cell motility is based on reorganization of the actin
cytoskeleton in lamellipodia at the leading cell edge. Rac is a
Rho-family small GTPase, which regulates rearrangement of the
actin network and is also involved in tumor metastasis. Eps8,
originally identified as a substrate of the epidermal growth factor
receptor (EGFR), serves as a Rac guanine nucleotide exchange fac-
tor thus activating Rac. Eps8 is involved in cancer cell invasive-
ness and motility in fibrosarcoma cells. Eps8 further binds actin
directly and possess barbed end capping activity.
Methods: Pancreatic tissue was obtained from patients that
underwent pancreatic resection at the University of Heidelberg.
Eight pancreatic cancer cell lines were used: AsPc-1, BxPC3,
Capan1, Colo357, Miapaca, Panc1, Su8686, and T3M4. QRT-PCR
was performed with the Light Cycler Fast Start DNA SYBR Green
Kit. Immunofluorescence of EGFR-GFP, actin and Eps8 was ana-
lysed by confocal microscopy. Cell motility was quantified by
the phagokinetic assay.
Results: QRT-PCR reveals that Eps8 expression is 4-fold increased
in pancreatic carcinoma compared to normal pancreatic tissue. In
pancreatic tissue, Eps8 is located apically in ductal epithelial cells.
In all eight pancreatic cell lines analysed, Eps8-expression corre-
lates with staging of the original tumors: cells derived from ascites
exhibit the strongest Eps8 expression, followed by cells from
metastases and primary tumors. In parallel, Eps8 expression in
cell lines is associated with increased cancer cell motility. Subcell-
ulary, Eps8 does not colocalize with the EGFR but is located at the
tip of actin filaments and at the leading cell edge.
Conclusion: Eps8 is increased in pancreatic cancer. Association
with dynamic actin at the leading cell edge in pancreatic cancer
cell lines seems to be an important mechanism for pancreatic
cancer cell migration promoting metastasis.
doi:10.1016/j.ejcsup.2006.04.069
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Background: Bone sialoprotein (BSP); an acidic glycoprotein that
plays a role in cancer cell growth, migration and invasion.
Methods: The expression, localisation and function of BSP in
chronic pancreatitis (CP) and pancreatic ductal adeno-carcinoma
E J C S U P P L E M E N T S 4 ( 2 0 0 6 ) 2 7 –5 3 31(PDAC) were analyzed by QRT-PCR, laser capture microdissection,
DNA microarray analysis, immunoblotting, radioimmunoassay,
immunohistochemistry, cell growth, invasion, scattering, and
adhesion assays.
Results: BSP mRNA was detected in 40.7% of normal, in 80% of
CP and in 86.4% of PDAC samples. The median BSP mRNA levels
were 6.1 and 0.9 and zero copies/ll cDNA in PDAC, CP and nor-
mal pancreatic tissues, respectively. BSP was localized in the
cytoplasm of the tubular complexes of CP and PDAC, and in pan-
creatic cancer cells. Five out of eight pancreatic cancer cell lines
expressed BSP mRNA. Recombinant BSP (rBSP) inhibited Capan-1
and SU8686 pancreatic cancer cell growth, with a maximal effect
of 46.4 ± 12.0% in Capan-1 cells and 45.7 ± 14.5% in SU8686
cells. rBSP decreased the invasion of SU8686 cells by
59.1 ± 11.2% and of Capan-1 cells by 13.3 ± 3.8% (p < 0.05),
whereas it did not affect scattering or adhesion of both cell
lines.
Conclusion: Endogenous BSP expression levels in pancreatic
cancer cells and low to absent BSP expression in the surrounding
stromal tissue elements may indirectly enhance the proliferation
and invasion of pancreatic cancer cells.
doi:10.1016/j.ejcsup.2006.04.070
P11. INFLUENCE OF NEUROENDOCRINE TUMOR
DIFFERENTIATION ON CELL ADHESION MOLECULE
EXPRESSION IN PROSTATIC CARCINOMA
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Universita¨tsklinikum Mannheim der Universita¨t Heidelberg, Germany.
Background: Neuroendocrine (NE) differentiated tumor cells can
be recurrently found in prostatic carcinoma (PCa). NE tumor are
involved in the proliferation of the surrounding tumor cells by
paracrine mechanisms. The loss of E-cadherin and b-catenin is
a central factor for local invasion and metastasis. To evaluate
the relationship between NE tumor differentiation and the
expression of E-cadherin and b-catenin was correlated with NE
differentiation.
Methods: This study included 102 previously untreated PCa tis-
sue specimens with a low (LNE) or high (HNE) NE differentiation.
The intensity and cellular localization of E-cadherin and b-cate-
nin was evaluated by immunohistochemistry. A homogeneous
membranous staining in >70% of the tumor cells was regarded
as normal, whereas an altered cellular distribution or heteroge-
neous staining in >30% of the tumor cells was regarded as aber-
rant. The expression of E-cadherin and b-catenin was correlated
with the NE differentiation.
Results: Aberrant expression of E-cadherin and b-catenin was
found in 72.7% and 90.2% of the tumors, respectively. In HNE
tumors aberrant expression was significantly increased com-
pared to LNE tumors (p = 0.010 for E-cadherin and p = 0.016 for
b-catenin). In addition, NE cells of which 78.2% were located at
the invasion front did not express E-cadherin or b-catenin as
demonstrated by comparing serial sections.
Conclusions: Tumors with a HNE differentiation have a sig-
nificantly decreased expression of the cell adhesion mole-
cules E-cadherin and b-catenin which were absent in theNE tumor cells. These results indicate that NE tumor cells
might influence the cell–cell adhesion by paracrine mecha-
nisms and play an important role in tumor progression and
invasiveness.
doi:10.1016/j.ejcsup.2006.04.071
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Background: Choroidal melanoma is the primary eye cancer in
adults, and displays some features in common with cutaneous
melanoma. MUC18 is an important diagnostic marker of cutane-
ous melanoma, with increased expression in tumors associated
with metastatic potential. However, MUC18 expression in primary
choroidal melanoma and melanocytes remains to be fully inves-
tigated. We examined a series of choroidal melanoma cell lines,
melanocytes, and primary choroidal melanomas, for a possible
association between MUC18 expression and more aggressive
forms of choroidal melanoma.
Methods: MUC18 expression (protein and mRNA) was assessed
in choroidal and metastatic melanoma cell lines using immu-
noblotting and RT-PCR. Sections of whole eyes with mixed
spindle/epithelioid choroidal melanomas (n = 18) were immuno-
labelled using a polyclonal antibody to the extracellular domain
of MUC18 (R&D), and visualised using peroxidase and
VectorRed.
Results: Immunoblotting of lysates from melanoma cells showed
a positive band 113 kDa, and MUC18 mRNA was detected in all
cell lines. Moderate/strong cytoplasmic MUC18 immunolabelling
was seen in 5/18 primary tumors (mixed spindle/epithelioid, <18
months detection to enucleation). MUC18 immunolabelling was
seen on tumor vasculature, and in some cases, on networks/chan-
nels, characteristic of more aggressive tumors. Tumor extracellu-
lar matrix showed MUC18 immunolabelling in some cases.
Conclusions: Melanoma cell lines all expressed MUC18, how-
ever, only some primary choroidal melanomas, mostly with fea-
tures suggesting more aggressive histopathology, expressed
moderate/strong MUC18 immunolabelling. These observations
suggest that MUC18 may play a role in tumor progression in some
cases, and may be an appropriate marker for more aggressive
choroidal melanomas.
doi:10.1016/j.ejcsup.2006.04.072
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